Study S002278

A Multi-centre, Prospective, Open-label, Single-arm, Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India

ClinicalTrials.gov record

Registration

Registration: NCT03070704
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2017-08-16
Primary completion: 2019-03-01
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes; Diabetes Mellitus, Type 2
Interventions: DRUG:insulin degludec/liraglutide
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1185-0871

Registered primary outcomes

Incidence of treatment emergent Adverse Events (AEs) [Year 0-1]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.